BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11460982)

  • 1. Immunology of pediatric heart transplantation: a clinical update.
    Webber SA
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2001; 4():158-84. PubMed ID: 11460982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunobiology of cardiac allograft and xenograft transplantation.
    Pietra BA; Gill RG
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2001; 4():123-57. PubMed ID: 11460981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15 years of pediatric heart transplantation at the University of Pittsburgh: lessons learned and future prospects.
    Webber SA
    Pediatr Transplant; 1997 Aug; 1(1):8-21. PubMed ID: 10084782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F; Kunitake H; Laks H; Odim J
    Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of HLA matching on survival in heart transplantation.
    Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
    Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing face of heart transplantation.
    Hunt SA; Haddad F
    J Am Coll Cardiol; 2008 Aug; 52(8):587-98. PubMed ID: 18702960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population.
    Pollock-BarZiv SM; den Hollander N; Ngan BY; Kantor P; McCrindle B; West LJ; Dipchand AI
    Circulation; 2007 Sep; 116(11 Suppl):I172-8. PubMed ID: 17846300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New evidence for a role of allograft accommodation in long-term tolerance.
    Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E
    Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
    Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
    J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary lung transplantation: the UCLA experience.
    Sherman W; Rabkin D; Ross D; Ardehali A;
    Clin Transpl; 2008; ():163-70. PubMed ID: 19708455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.
    Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE
    J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart transplantation at the Heart Center North Rhine-Westfalia.
    Tenderich G; Zittermann A; Schulz U; Schulte-Eistrup S; Schleithoff SS; Wlost S; Körfer R
    Clin Transpl; 2008; ():151-61. PubMed ID: 19708454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitisation and post-transplant course after the implantation of ventricular assist device.
    Malickaite R; Rucinskas K; Staneviciene A; Miniauskas S; Maneikiene V; Zuoziene G; Sirvydis V
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.